The S&P 500 Index ($SPX ) (SPY ) closed up +0.36% on Tuesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.68%.  December E-mini S&P futures (ESZ26 ) rose +0.36%, and December E-mini Nasdaq futures...

Stocks Finished Mostly Higher on Chipmaker Strength

The S&P 500 Index ($SPX ) (SPY ) is up +0.53% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.95%.  December E-mini S&P futures (ESZ26 ) are up +0.52%, and December E-mini Nasdaq futures...

Stocks Supported by Strength in Chipmakers

The S&P 500 Index ($SPX ) (SPY ) is up +0.32% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.59%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.91%.  December E-mini S&P futures (ESZ26 ) are up +0.24%, and December E-mini Nasdaq futures...

Stocks Rebound as Crude Oil Prices Fall and Chipmakers Recover

In early trading on Tuesday, shares of Revvity topped the list of the day's best performing components of the S&P 500 index, trading up 11.9%.  Year to date, Revvity registers a 75.4% gain.

And the worst performing S&P 500 component thus far on the day is Gartner, tradi

S&P 500 Movers: IT, RVTY  

(RTTNews) - Revvity, Inc. (RVTY) revealed earnings for its third quarter that Increases, from last year

Revvity, Inc. Profit Climbs In Q3 

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, International Paper Co (Symbol: IP) has taken over the #409 spot from Revvity Inc (Symbol: RVTY), according to The Online Investor.  

	Market capitalization is an import

International Paper Takes Over #409 Spot From Revvity 

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, and training and services; and instruments, reagents, and assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. It also develops technologies that enable and support genomic workflows using protein coupled receptors and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Revvity, Inc. News